Endovastec(SH:688016) Sou Hu Cai Jing·2025-05-29 12:17Company Overview - Shanghai MicroPort CardioFlow Medtech Co., Ltd. specializes in the research, production, and sales of interventional medical devices for aortic and peripheral blood vessels [2] - The main products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, intraoperative stents, balloon catheters, and stents [2] - The company has received several awards, including the Shanghai Government Quality Gold Award and recognition as one of the top 30 value companies on the Sci-Tech Innovation Board [2] Financial Performance - For Q1 2025, the company reported revenue of 332 million yuan, a year-on-year decrease of 7.23% [2] - The net profit for the same period was 130 million yuan, down 29.66% year-on-year, with a gross profit margin of 69.61% [2] Market Position - As of May 29, the company's stock closed at 88.0 yuan, with a rolling price-to-earnings (PE) ratio of 24.24 [1] - The average PE ratio in the medical device industry is 49.64, with a median of 36.36, placing the company at the 52nd position in the industry ranking [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 18,176, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]